ERBB2 and breast carcinoma: Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) serve as key biomarkers in breast cancer, and their expression in tumor cells forms the basis for endocrine therapy, targeted therapy and disease prognosis.